Hut 8 Corp vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Hut 8 Corp trades at $81.81 (market cap $11.01B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Hut 8 Corp is far larger — about 4.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Hut 8 Corp nearer its low. Which is the better fit depends on your goals.
| HUT | SLS | |
|---|---|---|
Market Cap | $11.01B | $2.28B |
Volume | 9,892,615 | 3,128,960 |
Sector | Financials | Health |
52-Week High | $133.02 | $15.46 |
52-Week Low | $33.76 | $1.39 |
Typical Hold Time | 11 Days | — |
Enterprise Value | $18.45B | $2.15B |
Signals from Pluang's Aura AI — not financial advice
HUT trades at $89.30, down 3.17% today, with a bearish technical signal and negative earnings momentum. The company reported significant losses with a net income margin of -188.59% despite revenue growth projections. Recent developments include a $1.07 billion credit facility expansion and strong analyst support with 93.75% buy ratings and a $156.79 consensus price target, suggesting substantial upside potential from current levels.
While HUT faces fundamental challenges with persistent losses and negative cash flow, the company's strategic pivot to AI infrastructure and substantial contract pipeline ($26.6B in long-term contracts) offers growth potential. Key risks include execution challenges in transitioning from mining operations and competitive pressures in the rapidly evolving AI infrastructure space. The stock presents a high-risk, high-reward opportunity with significant analyst optimism.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →